Streetbeat News

Analyst Ratings

ALB

Albemarle (NYSE:ALB) received mixed analyst ratings with 6 somewhat bullish, 6 indifferent, and 1 somewhat bearish. The average 12-month price target is now $168.85, down from $213.92, with a high estimate of $308.00 and a low of $128.00. Analysts from firms including TD Cowen, Mizuho, Oppenheimer, UBS, Deutsche Bank, Keybanc, B of A Securities, Piper Sandler, BMO Capital, and RBC Capital have adjusted their ratings and price targets. Albemarle's financial performance shows strong market recognition, revenue growth, profitability, and effective asset utilization, with a market cap above industry averages, a revenue growth rate of 10.46%, a net margin of 13.09%, an ROE of 3.07%, an ROA of 1.59%, and a healthy debt-to-equity ratio of 0.37.

Portfolio Pulse from Benzinga Insights

January 29, 2024 | 1:00 pm

NSC

Norfolk Southern Corp (NYSE:NSC) reported Q4 fiscal 2023 results with a 5% Y/Y decline in railway operating revenue and adjusted EPS below consensus. Shares fell 1.5% after the report. Analysts from Morgan Stanley, Stifel, and TD Cowen revised their price targets and ratings, with Morgan Stanley and Stifel downgrading the stock and TD Cowen slightly increasing the target but also downgrading the rating.

Portfolio Pulse from Avi Kapoor

January 29, 2024 | 12:56 pm

ZIM

ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) shares increased by 9.2% in pre-market trading following an upgrade from Hold to Buy by Jefferies, with a raised price target from $14 to $20. Other stocks also showed significant movement in pre-market trading, with various companies experiencing gains and losses. Notable gainers include NovaBay Pharmaceuticals, Inc. (NYSE:NBY) and Spectral AI, Inc. (NASDAQ:MDAI), while significant losers include Panbela Therapeutics, Inc. (NASDAQ:PBLA) and Aeva Technologies, Inc. (NYSE:AEVA).

Portfolio Pulse from Avi Kapoor

January 29, 2024 | 12:56 pm

BE

Bloom Energy's stock (BE) trades lower following a downgrade from Neutral to Underperform by B of A Securities.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 12:54 pm

KLAC

Susquehanna analyst Mehdi Hosseini has downgraded KLA (NASDAQ:KLAC) from Positive to Neutral while increasing the price target from $640 to $675.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 12:46 pm

AAL

ALVO

AXP

BELFB

DG

GOOGL

ONCT

RPD

WBD

ZIM

Several top Wall Street analysts have updated their price targets and ratings for various companies. Wells Fargo downgraded Warner Bros. Discovery (WBD) and cut its price target. Barclays upgraded Alvotech (ALVO) and raised its price target. Keybanc increased Alphabet Inc.'s (GOOGL) price target. JP Morgan raised Dollar General's (DG) price target but maintained an Underweight rating. Jefferies upgraded ZIM Integrated Shipping (ZIM) and raised its price target. Needham increased Bel Fuse Inc.'s (BELFB) price target. Barclays raised American Express (AXP) price target. HC Wainwright & Co. significantly raised Oncternal Therapeutics' (ONCT) price target. UBS upgraded Rapid7 (RPD) and increased its price target. Citigroup upgraded American Airlines (AAL) and boosted its price target.

Portfolio Pulse from Avi Kapoor

January 29, 2024 | 12:34 pm

BE

B of A Securities analyst Julien Dumoulin-Smith downgraded Bloom Energy (NYSE:BE) from Neutral to Underperform and reduced the price target from $16 to $10, indicating a bearish outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 12:32 pm

RVNC

Mizuho analyst Vamil Divan has downgraded Revance Therapeutics (NASDAQ:RVNC) from Buy to Neutral and reduced the price target from $16 to $9, indicating a more cautious outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 12:28 pm

NSC

TD Cowen analyst Jason Seidl downgraded Norfolk Southern (NYSE:NSC) from Outperform to Market Perform while raising the price target from $233 to $236.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 12:26 pm

MAR

Barclays analyst Brandt Montour has maintained an Equal-Weight rating on Marriott International (NASDAQ:MAR) and increased the price target from $208 to $234. This adjustment reflects a positive view on the stock's potential performance.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 12:21 pm